| 000 | 01783 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250516204023.0 | ||
| 264 | 0 | _c20141209 | |
| 008 | 201412s 0 0 eng d | ||
| 022 | _a1791-2423 | ||
| 024 | 7 |
_a10.3892/ijo.2014.2357 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDuong, Hong-Quan | |
| 245 | 0 | 0 |
_aCombination of dasatinib and gemcitabine reduces the ALDH1A1 expression and the proliferation of gemcitabine-resistant pancreatic cancer MIA PaCa-2 cells. _h[electronic resource] |
| 260 |
_bInternational journal of oncology _cJun 2014 |
||
| 300 |
_a2132-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAldehyde Dehydrogenase _xgenetics |
| 650 | 0 | 4 | _aAldehyde Dehydrogenase 1 Family |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 | _aAntineoplastic Combined Chemotherapy Protocols |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 | _aDasatinib |
| 650 | 0 | 4 |
_aDeoxycytidine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aDrug Resistance, Neoplasm _xdrug effects |
| 650 | 0 | 4 |
_aGene Expression Regulation, Neoplastic _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPancreatic Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aPyrimidines _xpharmacology |
| 650 | 0 | 4 | _aRetinal Dehydrogenase |
| 650 | 0 | 4 |
_aThiazoles _xpharmacology |
| 650 | 0 | 4 | _aGemcitabine |
| 700 | 1 | _aYi, Yong Weon | |
| 700 | 1 | _aKang, Hyo Jin | |
| 700 | 1 | _aBae, Insoo | |
| 700 | 1 | _aJang, Young-Joo | |
| 700 | 1 | _aKwak, Sahng-June | |
| 700 | 1 | _aSeong, Yeon-Sun | |
| 773 | 0 |
_tInternational journal of oncology _gvol. 44 _gno. 6 _gp. 2132-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3892/ijo.2014.2357 _zAvailable from publisher's website |
| 999 |
_c23684092 _d23684092 |
||